Deep Health AI India Defers FY26 Financial Results to May 29

Deep Health AI India Limited has deferred consideration of its audited standalone and consolidated financial results for FY26 from May 27 to May 29, 2026. The company filed a revised board meeting outcome correcting typographical errors from its earlier submission.

1 min read Deep Health AI India

Board Defers Financial Results Consideration

Deep Health AI India Limited has rescheduled the consideration of its audited financial results for the financial year ended March 31, 2026. The Board of Directors, which convened on May 27, 2026, deferred the agenda item pertaining to the approval of both standalone and consolidated financial results along with the draft statutory auditor's report.

The matter will now be taken up for consideration on Friday, May 29, 2026, according to the company's filing with the Bombay Stock Exchange. The announcement falls under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Revised Filing Corrects Earlier Errors

The company submitted a revised board meeting outcome that supersedes its earlier filing dated May 27, 2026. The revision addresses typographical errors present in the original submission. Deep Health AI India has requested stakeholders to consider the revised outcome as the official replacement document.

The deferred agenda covers the audited standalone and consolidated financial results for the full fiscal year ending March 31, 2026, along with the accompanying statutory auditor's report in draft form.

Timeline of Announcements

  • May 22, 2026: Company initially informed about Board meeting scheduled for May 27, 2026
  • May 27, 2026: Board meeting held; initial outcome filed
  • May 27, 2026: Revised outcome submitted correcting typographical errors
  • May 29, 2026: Financial results now scheduled for consideration

Compliance Context

Regulation 33 of the SEBI (LODR) Regulations, 2015 mandates listed companies to disclose audited financial results on a quarterly and annual basis. The regulation prescribes specific formats and timelines for such disclosures, ensuring transparency and timely information flow to shareholders and market participants.

The deferral from May 27 to May 29, 2026, represents a brief extension in the approval timeline. Investors and market participants monitoring Deep Health AI India Limited on the BSE should note the updated schedule for the FY26 financial results announcement.

This article is based solely on publicly available corporate filings submitted by Deep Health AI India Limited to the Bombay Stock Exchange. The information provided is for informational purposes only and should not be construed as financial or investment advice. Readers are advised to refer to official exchange filings and consult qualified financial advisors before making investment decisions.

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#Deep Health AI India Ltd #DDIL #Corporate announcement
MARKET INTELLIGENCE

Track Indian stocks with ZTOX AI

NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.

Free
Essential tracking to get started
₹0
  • Track 5 companies
  • News, NSE/BSE & insider alerts
  • Daily FII/DII activity
POPULAR
Basic
For active investors
₹89/mo
  • Track 20 companies
  • Everything in Free
  • Results, volume & live gainer alerts
Advanced
Deeper market signals
₹119/mo
  • Track 50 companies
  • Everything in Basic
  • Block deals & 60-day volume breakouts

Need more? Pro tracks up to 500 companies with preferential issue alerts.

Start free

No credit card required. Connect WhatsApp or Telegram in minutes.